General Information of the Compound
| Compound ID |
CP0943485
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[[[[4,7,10-Tris(carboxymethyl)-1,4,7,10 tetraazacyclododec-1-yl]acetyl]glycyl]amino]-L-Lysinyl-(3,6,9)-trloxaundecane-l,11-dicarboxylicacid-3,7-dideoxy-3-aminocholic acid)-L-arginyl-L-glutaminyl-L-triptophyl-L-alanyl-L-valyl-glycyl-L-histidyl-L-leucyl-L-methioninamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C106H171N25O27S
|
||||||||||||||||||
| Molecular Weight |
2259.749
|
||||||||||||||||||
| Canonical SMILES |
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)COCCOCCOCC(=O)N[C@H]1CC[C@]2(C)[C@H]3C[C@H](O)[C@]4(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]4[C@@H]3CC[C@]2(C)C1)NC(=O)CNC(=O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1)C(C)C)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C106H171N25O27S/c1-62(2)46-79(100(153)122-75(94(108)147)28-45-159-10)125-101(154)81(48-68-52-111-61-117-68)121-85(135)54-116-102(155)93(63(3)4)127-95(148)65(6)118-99(152)80(47-66-51-114-74-17-12-11-16-69(66)74)126-98(151)78(23-24-83(107)133)124-97(150)77(19-15-32-113-103(109)110)123-96(149)76(120-84(134)53-115-86(136)55-128-33-35-129(56-90(141)142)37-39-131(58-92(145)146)40-38-130(36-34-128)57-91(143)144)18-13-14-31-112-87(137)59-157-43-41-156-42-44-158-60-88(138)119-67-26-30-105(8)73-49-82(132)106(9)71(64(5)20-25-89(139)140)21-22-72(106)70(73)27-29-104(105,7)50-67/h11-12,16-17,51-52,61-65,67,70-73,75-82,93,114,132H,13-15,18-50,53-60H2,1-10H3,(H2,107,133)(H2,108,147)(H,111,117)(H,112,137)(H,115,136)(H,116,155)(H,118,152)(H,119,138)(H,120,134)(H,121,135)(H,122,153)(H,123,149)(H,124,150)(H,125,154)(H,126,151)(H,127,148)(H,139,140)(H,141,142)(H,143,144)(H,145,146)(H4,109,110,113)/t64-,65+,67+,70+,71-,72+,73+,75+,76+,77+,78+,79+,80+,81+,82+,93+,104-,105-,106-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QCWUAIPOJMRATR-VPJPZRCRSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound